Antimicrobial Peptide Design, Molecular Docking and ADMET Studies Against the Methicillin-Resistant Staphylococcus aureus and Carbapenem resistant and Carbapenemase-producing Pseudomonas aeruginosa

Simple item page
dc.contributor.authorAliyu Abdulmalik
dc.date.accessioned2024-04-17T08:37:10Z
dc.date.available2024-04-17T08:37:10Z
dc.date.issued2022-10
dc.description.abstractCarbapenem-resistant and carbapenemase-producing Pseudomonas aeruginosa (CRPA) and methicillin-resistant Staphylococcus aureus (MRSA) are two pathogens that are resistant to currently available antimicrobials. As an alternative to effective medication molecules, antimicrobial peptides (AMPs) have the potential to cure superbug-caused infections effectively. Two new AMPs (ama1 and ama2) were designed utilizing a knowledge-based technique with optimal parameters. First, the PEP-FOLD 3.5 server made a de novo prediction of the AMPs' three-dimensional (3D) structure, which was validated using PROCHECK of SAVES v6.0 by checking the amino acid locations in the Ramachandra plot. Then, protein-peptide docking simulations of the predicted AMPs and reference AMP (Aurein 1.2) for positive control were performed using the HPEPDOCK docking web server, followed by the computation of the AMPs' physicochemical parameters and toxicity profile using the ProtParam and vNN-ADMET web servers, respectively. The sequences for ama1 and ama2 were AWGKIKALR and IKWLRLAKP, respectively. Docking analysis revealed that the antibacterial activity of ama1 and ama2 was superior to that of Aurein 1.2 against CRPA-resistant enzyme (6ew3), respectively. However, ama1, ama2, and Aurein 1.2 inhibited the activity of MRSA-resistant protein (4c12). Both the physicochemical qualities and the toxicity profiles were advantageous. Therefore, the in-silico-derived AMPs could serve as a pharmaceutical candidate for developing multidrug-resistant bacteria-effective antimicrobials.
dc.identifier.urihttps://uilspace.unilorin.edu.ng/handle/123456789/11981
dc.publisherTrends in Peptide and Peptide Sciences
dc.subjectAntimicrobial peptides
dc.subjectMolecular docking Pseudomonas aeruginosa Pharmacokinetic parameters Resistant pathogens Staphylococcus aureus
dc.titleAntimicrobial Peptide Design, Molecular Docking and ADMET Studies Against the Methicillin-Resistant Staphylococcus aureus and Carbapenem resistant and Carbapenemase-producing Pseudomonas aeruginosa

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Antimicrobial Peptide Design, Molecular Docking and ADMET Studies.pdf
Size:
604.41 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections